Reinforcing integrated psychiatric service attendance in an opioid-agonist program: A randomized and controlled trial

Drug and Alcohol Dependence

Volumn 133, Issue 1, 2013, Pages 30-36

  Kidorf, Michael ^a   Brooner, Robert K ^a   Gandotra, Neeraj ^a   Antoine, Denis ^a   King, Van L ^a   Peirce, Jessica ^a   Ghazarian, Sharon ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Contingency management; Methadone maintenance; Psychiatric comorbidity; Treatment adherence

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; HETEROCYCLIC COMPOUND; METHADONE; MOOD STABILIZER; NEUROLEPTIC AGENT; OPIATE AGONIST; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; COMMUNITY PROGRAM; CONTROLLED STUDY; DISTRESS SYNDROME; DRUG MEGADOSE; DRUG URINE LEVEL; FEMALE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; INTEGRATED HEALTH CARE SYSTEM; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH SERVICE; METHADONE TREATMENT; OPIATE ADDICTION; OUTPATIENT; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT SCHEDULING; PRIORITY JOURNAL; PSYCHIATRIST; RANDOMIZED CONTROLLED TRIAL; REINFORCED ON SITE INTEGRATED CARE; STANDARD ON SITE INTEGRATED CARE; TREATMENT DURATION; TREATMENT RESPONSE; URINALYSIS;

CONTINGENCY MANAGEMENT; METHADONE MAINTENANCE; PSYCHIATRIC COMORBIDITY; TREATMENT ADHERENCE;

ADULT; COUNSELING; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MENTAL DISORDERS; MENTAL HEALTH SERVICES; OPIOID-RELATED DISORDERS; PATIENT ACCEPTANCE OF HEALTH CARE; REINFORCEMENT (PSYCHOLOGY); SUBSTANCE ABUSE TREATMENT CENTERS;

EID: 84884416160     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2013.06.005     Document Type: Article

References (39)

1. Bowen R.C., D'Arcy C., Keegan D., Senthilselvan A. A controlled trial of cognitive behavioral treatment of panic in alcoholic inpatients with comorbid panic disorder. Addict. Behav. 2000, 25:593-597.
2. Brooner R.K., Kidorf M.S., King V.L., Stoller K.B., Neufeld K., Kolodner K. Comparing adaptive stepped care and monetary voucher interventions in the treatment of opioid dependent outpatients. Drug Alcohol Depend. 2007, 88S:S14-S23.
3. Brooner R.K., Kidorf M.S., King V.L., Stoller K.B., Peirce J.M., Bigelow G.E., Kolodner K. Behavioral contingencies improve counseling attendance in an adaptive treatment model. J. Subst. Abuse Treat. 2004, 27:223-232.
4. Brooner R.K., King V.L., Kidorf M., Schmidt C.W., Bigelow G.E. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch. Gen. Psychiatry 1997, 54:71-80.
5. Carroll K.M., Nich C., Shi J., Eagan D., Ball S.A. Efficacy of disulfiram and twelve step facilitation in cocaine-dependent individuals maintained on methadone: a randomized placebo-controlled trial. Drug Alcohol Depend. 2012, 126:224-231.
6. Carroll K.M., Rounsaville B.J., Nich C., Gordon L.T., Wirtz P.W., Gawin F.H. One year follow-up of psychotherapy and pharmacotherapy for cocaine dependence: delayed emergence of psychotherapy effects. Arch. Gen. Psychiatry 1994, 51:989-997.
7. Center for Substance Abuse Treatment Substance Abuse Treatment for Persons with Co-occurring Disorders. TIP series 42 No. DHHS Publication No. (SMA) 05-3922 2005, Center for Substance Abuse Treatment, Rockville, MD.
8. Derogatis L.R. SCL-90-R. Administration, Scoring, and Procedures Manual II 1983, Clinical Psychometric Research, Baltimore, MD.
9. Derogatis L.R., Cleary P.A. Factorial invariance across gender for the primary symptom dimensions of the SCL-90. Br. J. Soc. Clin. Psychol. 1977, 16:347-356.
10. Donald M., Dower J., Kavanagh D. Integrated versus non-integrated management and care for clients with co-occurring mental health and substance use disorders: a qualitative systematic review of randomized controlled trials. Soc. Sci. Med. 2005, 60:1371-1383.
11. Drake R.E., O'Neal E.L., Wallach M.A. A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. J. Subst. Abuse Treat. 2008, 34:123-138.
12. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis Disorders - Patient Edition (SCID-I/P, Version 2.0) 1995, New York State Psychiatric Institute, New York.
13. Helmus T.C., Saules K.K., Schoener E.P., Roll J.M. Reinforcement of counseling attendance and alcohol abstinence in a community-based dual-diagnosis treatment program: a feasibility study. Psychol. Addict. Behav. 2003, 17:249-251.
14. Higgins S.T., Heil S.H., Lussier J.P. Clinical implications of reinforcement as a determinant of substance use disorders. Annu. Rev. Psychol. 2004, 55:431-461.
15. Jones H.E., Haug N., Silverman K., Stitzer M., Svikis D. The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women. Drug Alcohol Depend. 2001, 61:297-306.
16. Kidorf M., Disney E.R., King V.L., Neufeld K., Beilenson P.L., Brooner R.K. Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. Drug Alcohol Depend. 2004, 74:115-122.
17. Kidorf M., King V.L., Brooner R.K. Counseling and psychosocial services. The Treatment of Opioid Dependence 2006, 119-150. Johns Hopkins University Press, Baltimore. E.C. Strain, M.L. Stitzer (Eds.).
18. Kidorf M., King V.L., Neufeld K., Pierce J., Kolodner K., Brooner R.K. Improving substance abuse treatment enrollment in community syringe exchangers. Addiction 2009, 104:786-795.
19. Kidorf M., King V.L., Neufeld K., Stoller K.B., Peirce J., Brooner R.K. Involving significant others in the care of patients receiving methadone. J. Subst. Abuse Treat. 2005, 29:19-27.
20. Lussier J.P., Heil S.H., Mongeon J.A., Badger G.J., Higgins S.T. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 2006, 101:192-203.
21. Lydecker K.P., Tate S.R., Cummins K.M., McQuaid J., Granholm E., Brown S.A. Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychol. Addict. Behav. 2010, 24:453-465.
22. McGovern M.P., Xie H., Segal S.R., Siembab L., Drake R.E. Addiction treatment services and co-occurring disorders. J. Subst. Abuse Treat. 2006, 31:267-275.
23. McLellan A.T., Cacciola J.C., Alterman A.I., Rikoon S.H., Carise D. The Addiction Severity Index at 25: origins, contributions and transitions. Am. J. Addict. 2006, 15:113-124.
24. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Pettinati H., Argeriou M. The fifth edition of the addiction severity index. J. Subst. Abuse Treat. 1992, 9:199-213.
25. Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med. Care 1986, 24:67-74.
26. Mueser K.T., Deavers T., Penn D.L., Classisi J.E. Psychosocial treatments for schizophrenia. Annu. Rev. Clin. Psychol. 2013, 9:465-497.
27. Nunes E.V., Quitkin F.M., Donovan S.J., Deliyannides D., McGrath P.J., Woody G. Imipramine treatment of opiate dependent patients with depressive disorders. Arch. Gen. Psychiatry 1998, 55:153-160.
28. Pampallona S., Bollini P., Tibaldi G., Kupelnick B., Munizza C. Combined pharmacotherapy and psychological treatment for depression: a systematic review. Arch. Gen. Psychiatry 2004, 61:714-719.
29. Petry N.M., Martin B.M., Simcic F. Prize reinforcement contingency management for cocaine dependence: integration with group therapy in a methadone clinic. J. Consult. Clin. Psychol. 2005, 73:354-359.
30. Pringle J.L., Emptage N.P., Hubbard R.L. Unmet needs for comprehensive services in outpatient addiction treatment. J. Subst. Abuse Treat. 2006, 30:183-189.
31. Randall C., Thomas S., Thevos A.K. Concurrent alcoholism and social anxiety disorder: a first step toward developing effective treatments. Alcohol. Clin. Exp. Res. 2001, 25:210-220.
32. Rawson R.A., Huber A., McCann M., Shoptaw S., Farabbee D., Reiber C., Ling W. A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence. Arch. Gen. Psychiatry 2002, 59:817-824.
33. Adherence to Long-term Therapies: Evidence for Action 2003, World Health Organization, Geneva. http://whqlibdoc.who.int/publications/2003/9241545992.pdf, E. Sabate (Ed.).
34. Sacks S., Chandler R., Gonzales J. Responding to the challenge of co-occurring disorders: suggestions for future research. J. Subst. Abuse Treat. 2008, 34:139-146.
35. Sacks S., McKendrick K., Sacks J., Banks S., Harle M. Enhanced outpatient treatment for co-occurring disorders: main outcomes. J. Subst. Abuse Treat. 2008, 34:48-60.
36. Sorensen J.L., Haug N.A., Delucchi K.L., Gruber V., Kletter E., Batki S.L., Tulsky J.P., Barnett P., Hall S. Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial. Drug Alcohol Depend. 2007, 88:54-63.
37. Wampold B.E., Minami T., Baskin T.W., Callen T.S. A meta-(re)analysis of the effects of cognitive therapy versus other therapies for depression. J. Affect. Disord. 2002, 68:159-165.
38. Watkins K.E., Hunter S.B., Hepner K.A., Paddock S.M., de la Cruz E., Zhou A.J., Gilmore J. An effectiveness trial of group cognitive behavioral therapy for patients with persistent depressive symptoms in substance abuse treatment. Arch. Gen. Psychiatry 2011, 68:577-584.
39. Weiss R.D., Griffin M.L., Kolodziej M.E., Greenfield S.F., Najavits L.M., Daley D.C., Doreau H.R., Hennen J.A. A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence. Am. J. Psychiatry 2007, 164:100-107.